What is the difference between Ixifi and Remicade?
Medically reviewed by Drugs.com. Last updated on Sep 17, 2019.
Official Answer
by Drugs.comIxifi (infliximab-qbtx) is a tumor necrosis factor (TNF) blocker that is biosimilar to Remicade (infliximab).
Biosimilars are approved through an abbreviated licensure pathway for biological products that are shown to be interchangeable with an already FDA-approved biological product.
What Are Biosimilars? Top Facts You May Not Know
Ixifi and Remicade are used for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Ixifi is not interchangeable with Remicade at the pharmacy level unless specifically noted by the prescribing doctor.
For more information, see Comparing Ixifi vs Remicade
Related Medical Questions
- How long does it take for methotrexate to work?
- What is a substitute for fluocinonide cream?
- What are the new drugs for the treatment of plaque psoriasis?
- Halobetasol vs. clobetasol - how do they compare?
- How long does methotrexate stay in your system?
- Is fluocinonide an antifungal cream?
- How long can you use betamethasone cream for?
Drug Information
Related Support Groups
- Psoriasis (52 questions, 269 members)
- Remicade (20 questions, 178 members)
- Infliximab
- Ixifi
- Rheumatoid Arthritis (231 questions, 1222 members)
- Crohn's Disease (30 questions, 268 members)
- Psoriatic Arthritis (29 questions, 240 members)
- Ulcerative Colitis (29 questions, 172 members)
- Plaque Psoriasis (30 questions, 63 members)
- Inflammatory Bowel Disease
- Ankylosing Spondylitis (18 questions, 195 members)
- Toxic Epidermal Necrolysis
